isosilybin

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2018
02419922018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Because cancer is often treated with combination therapy, unexpected pharmacological effects can occur because of drug-drug… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2013
2013
This study demonstrates how regio- and diastereo-isomers with near-identical NMR spectra can be distinguished and unambiguously… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2012
2012
Isosilybin A (1) is one of the major flavonolignans that constitute silymarin, an extract of the fruits (achenes) of milk thistle… (More)
Is this relevant?
2010
2010
Prostate cancer (PCA) is the second most malignancy in American men. Advanced stage PCA cells possess unlimited replication… (More)
Is this relevant?
2007
2007
Silymarin and, one of its constituents, silibinin exert strong efficacy against prostate cancer (PCA); however, anticancer… (More)
Is this relevant?
2007
2007
Extracts of milk thistle ( Silybum marianum, Asteraceae), termed "silymarin," are used worldwide, primarily for hepatoprotective… (More)
Is this relevant?
2006
2006
A selective and sensitive liquid chromatography/tandem mass spectrometry (LC/MS/MS) method has been developed for the… (More)
Is this relevant?
2003
2003
Silymarin is an antihepatotoxic substance isolated from fruits of Silybum marianum. Possibly due to their antioxidant and… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
1993
1993
The plasma level profile and the biliary excretion of silybin, the main flavanolignan component of silymarin, were evaluated in… (More)
  • figure 1
  • table 11
  • figure 3
  • table III
  • figure 4
Is this relevant?
1992
1992
The biliary excretion of silybin, the main active component of silymarin, was evaluated by using a specific HPLC method in 9… (More)
Is this relevant?